This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Patick, A. K.
Right arrow Articles by Potts, K. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Patick, A. K.
Right arrow Articles by Potts, K. E.

 Previous Article  |  Next Article 

Clinical Microbiology Reviews, October 1998, p. 614-627, Vol. 11, No. 4
0893-8512/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Protease Inhibitors as Antiviral Agents

A. K. Patick* and K. E. Potts

Agouron Pharmaceuticals, Inc., San Diego, California 92121

Currently, there are a number of approved antiviral agents for use in the treatment of viral infections. However, many instances exist in which the use of a second antiviral agent would be beneficial because it would allow the option of either an alternative or a combination therapeutic approach. Accordingly, virus-encoded proteases have emerged as new targets for antiviral intervention. Molecular studies have indicated that viral proteases play a critical role in the life cycle of many viruses by effecting the cleavage of high-molecular-weight viral polyprotein precursors to yield functional products or by catalyzing the processing of the structural proteins necessary for assembly and morphogenesis of virus particles. This review summarizes some of the important general features of virus-encoded proteases and highlights new advances and/or specific challenges that are associated with the research and development of viral protease inhibitors. Specifically, the viral proteases encoded by the herpesvirus, retrovirus, hepatitis C virus, and human rhinovirus families are discussed.

* Corresponding author. Mailing address: Department of Virology, Agouron Pharmaceuticals, Inc., 4245 Sorrento Valley Blvd., San Diego, CA 92121. Phone: (619) 622-3117. Fax: (619) 622-5999. E-mail: patick{at}agouron.com.

Clinical Microbiology Reviews, October 1998, p. 614-627, Vol. 11, No. 4
0893-8512/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Tsai, M.-T., Cheng, Y.-H., Liu, Y.-N., Liao, N.-C., Lu, W.-W., Kung, S.-H. (2009). Real-Time Monitoring of Human Enterovirus (HEV)-Infected Cells and Anti-HEV 3C Protease Potency by Fluorescence Resonance Energy Transfer. Antimicrob. Agents Chemother. 53: 748-755 [Abstract] [Full Text]  
  • Martinez, F. J. (2007). Pathogen-directed Therapy in Acute Exacerbations of Chronic Obstructive Pulmonary Disease. Proc Am Thorac Soc 4: 647-658 [Abstract] [Full Text]  
  • Binford, S. L., Weady, P. T., Maldonado, F., Brothers, M. A., Matthews, D. A., Patick, A. K. (2007). In Vitro Resistance Study of Rupintrivir, a Novel Inhibitor of Human Rhinovirus 3C Protease. Antimicrob. Agents Chemother. 51: 4366-4373 [Abstract] [Full Text]  
  • Hwang, Y.-C., Chen, W., Yates, M. V. (2006). Use of fluorescence resonance energy transfer for rapid detection of enteroviral infection in vivo.. Appl. Environ. Microbiol. 72: 3710-3715 [Abstract] [Full Text]  
  • Binford, S. L., Maldonado, F., Brothers, M. A., Weady, P. T., Zalman, L. S., Meador, J. W. III, Matthews, D. A., Patick, A. K. (2005). Conservation of Amino Acids in Human Rhinovirus 3C Protease Correlates with Broad-Spectrum Antiviral Activity of Rupintrivir, a Novel Human Rhinovirus 3C Protease Inhibitor. Antimicrob. Agents Chemother. 49: 619-626 [Abstract] [Full Text]  
  • Naqvi, T., Lim, A., Rouhani, R., Singh, R., Eglen, R. M. (2004). Galactosidase Enzyme Fragment Complementation as a High-Throughput Screening Protease Technology. J Biomol Screen 9: 398-408 [Abstract]  
  • Hayden, F. G., Turner, R. B., Gwaltney, J. M., Chi-Burris, K., Gersten, M., Hsyu, P., Patick, A. K., Smith, G. J. III, Zalman, L. S. (2003). Phase II, Randomized, Double-Blind, Placebo-Controlled Studies of Ruprintrivir Nasal Spray 2-Percent Suspension for Prevention and Treatment of Experimentally Induced Rhinovirus Colds in Healthy Volunteers. Antimicrob. Agents Chemother. 47: 3907-3916 [Abstract] [Full Text]  
  • Hommer, V., Eichholz, J., Petry, F. (2003). Effect of antiretroviral protease inhibitors alone, and in combination with paromomycin, on the excystation, invasion and in vitro development of Cryptosporidium parvum. J Antimicrob Chemother 52: 359-364 [Abstract] [Full Text]  
  • Whitney, M., Stack, J. H., Darke, P. L., Zheng, W., Terzo, J., Inglese, J., Strulovicil, B., Kuo, L. C., Pollok, B. A. (2002). A Collaborative Screening Program for the Discovery of Inhibitors of HCV NS2/3 cis-Cleaving Protease Activity. J Biomol Screen 7: 149-154 [Abstract]  
  • Broo, K., Wei, J., Marshall, D., Brown, F., Smith, T. J., Johnson, J. E., Schneemann, A., Siuzdak, G. (2001). Viral capsid mobility: A dynamic conduit for inactivation. Proc. Natl. Acad. Sci. USA 10.1073/pnas.051598298v1 [Abstract] [Full Text]  
  • Zalman, L. S., Brothers, M. A., Dragovich, P. S., Zhou, R., Prins, T. J., Worland, S. T., Patick, A. K. (2000). Inhibition of Human Rhinovirus-Induced Cytokine Production by AG7088, a Human Rhinovirus 3C Protease Inhibitor. Antimicrob. Agents Chemother. 44: 1236-1241 [Abstract] [Full Text]  
  • Hamilton-Miller, J. M. T. (1999). {beta}-Lactams: variations on a chemical theme, with some surprising biological results. J Antimicrob Chemother 44: 729-734 [Full Text]  
  • Patick, A. K., Binford, S. L., Brothers, M. A., Jackson, R. L., Ford, C. E., Diem, M. D., Maldonado, F., Dragovich, P. S., Zhou, R., Prins, T. J., Fuhrman, S. A., Meador, J. W., Zalman, L. S., Matthews, D. A., Worland, S. T. (1999). In Vitro Antiviral Activity of AG7088, a Potent Inhibitor of Human Rhinovirus 3C Protease. Antimicrob. Agents Chemother. 43: 2444-2450 [Abstract] [Full Text]  
  • Broo, K., Wei, J., Marshall, D., Brown, F., Smith, T. J., Johnson, J. E., Schneemann, A., Siuzdak, G. (2001). Viral capsid mobility: A dynamic conduit for inactivation. Proc. Natl. Acad. Sci. USA 98: 2274-2277 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»